These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 2446786)
1. Methylisobutylxanthine, a potent inhibitor of cAMP phosphodiesterase, enhances the sensitivity of Chinese hamster ovary cells to mitomycin C. Otsu Y; Kimura H; Aoyama T Chem Biol Interact; 1987; 64(1-2):13-22. PubMed ID: 2446786 [TBL] [Abstract][Full Text] [Related]
2. Cell line-dependent changes in sensitivity to mitomycin C by 1-methyl-3-isobutylxanthine is due to an altered intracellular dose of the anticancer drug and/or to changes in DT-diaphorase activity. Kimura H; Terado T; Aoyama T Biol Pharm Bull; 1994 Sep; 17(9):1187-92. PubMed ID: 7531052 [TBL] [Abstract][Full Text] [Related]
3. Paradoxical stimulation by 1-methyl-3-isobutylxanthine of rat liver cyclic AMP phosphodiesterase activity. Erneux C; Miot F; Boeynaems JM; Dumont JE FEBS Lett; 1982 Jun; 142(2):251-4. PubMed ID: 6179796 [No Abstract] [Full Text] [Related]
4. Methylxanthine inhibitors of phosphodiesterases. Wells JN; Miller JR Methods Enzymol; 1988; 159():489-96. PubMed ID: 2457788 [No Abstract] [Full Text] [Related]
5. Modification of the sensitivity of CHO cells to mitomycin C by dibutyryl cyclic AMP. Shinohara S; Otsu Y; Yamada T; Kimura H; Aoyama T Biochem Biophys Res Commun; 1983 Feb; 111(1):247-52. PubMed ID: 6299289 [TBL] [Abstract][Full Text] [Related]
6. In vitro regulation of human monocyte insulin receptors by insulin and 1-methyl-3-isobutylxanthine. Whitson RH; Kaplan SA Am J Physiol; 1983 Nov; 245(5 Pt 1):E494-501. PubMed ID: 6195925 [TBL] [Abstract][Full Text] [Related]
7. Anagrelide: a potent and selective inhibitor of platelet cyclic AMP phosphodiesterase enzyme activity. Gillespie E Biochem Pharmacol; 1988 Jul; 37(14):2866-8. PubMed ID: 2456068 [No Abstract] [Full Text] [Related]
8. Interactions of a phosphodiesterase inhibitor, 3-isobutyl-1-methyl xanthine, with prostaglandin E2, follicle-stimulating hormone, luteinizing hormone, and dibutyryl cyclic 3',5'-adenosine monophosphate (cAMP) in cAMP and steroid production by neonatal rat ovaries in vitro. Reddoch RB; Armstrong DT Endocrinology; 1984 Jul; 115(1):11-8. PubMed ID: 6203725 [TBL] [Abstract][Full Text] [Related]
9. Adenosine 3',5'-phosphate phosphodiesterase and pheromone response in the yeast Saccharomyces cerevisiae. Liao HH; Thorner J J Bacteriol; 1981 Dec; 148(3):919-25. PubMed ID: 6171560 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of cyclic AMP phosphodiesterase activity and myocardial contractility: effects of cilostamide, a novel PDE inhibitor, and methylsiobutylxanthine on rabbit and canine ventricular muscle. Endoh M; Satoh K; Yamashita S Eur J Pharmacol; 1980 Aug; 66(1):43-52. PubMed ID: 6157546 [No Abstract] [Full Text] [Related]
11. Activation of human lymphocyte high affinity cyclic AMP phosphodiesterase by culture with 1-methyl-3-isobutylxanthine. Thompson WJ; Ross CP; Hersh EM; Epstein PM; Strada SJ J Cyclic Nucleotide Res; 1980; 6(1):25-36. PubMed ID: 6155390 [TBL] [Abstract][Full Text] [Related]
12. Inhibitory characteristics of prostaglandin F2 alpha in the rat luteal cell. Dorflinger LJ; Luborsky JL; Gore SD; Behrman HR Mol Cell Endocrinol; 1983 Dec; 33(2-3):225-41. PubMed ID: 6197325 [TBL] [Abstract][Full Text] [Related]
13. Morphological transformation of Chinese hamster cells by acylpeptides, inhibitors of cAMP phosphodiesterase, produced by Bacillus subtilis. Hosono K; Suzuki H J Biol Chem; 1985 Sep; 260(20):11252-5. PubMed ID: 2993305 [TBL] [Abstract][Full Text] [Related]
14. The effects of alkylated xanthines on cyclic AMP accumulation in dog thyroid slices exposed to carbamylcholine. Miot F; Erneux C; Wells JN; Dumont JE Mol Pharmacol; 1984 Mar; 25(2):261-6. PubMed ID: 6321949 [TBL] [Abstract][Full Text] [Related]
15. Radioprotection of mouse intestine by inhibitors of cyclic AMP phosphodiesterase. Lehnert S Int J Radiat Oncol Biol Phys; 1979 Jun; 5(6):825-33. PubMed ID: 91600 [No Abstract] [Full Text] [Related]
16. [The relationship between the intracellular content of 1-methyl-3-isobutylxanthine and the permeability for water of the bladder wall in the frog]. Natochin IuV; Parnova RG; Firsov DL; Shakhmatova EI; Kaminskiĭ IuL Fiziol Zh SSSR Im I M Sechenova; 1989 Dec; 75(12):1766-71. PubMed ID: 2483381 [TBL] [Abstract][Full Text] [Related]
17. Activation of cyclic GMP-binding and cyclic AMP-specific phosphodiesterases of rat platelets by a mechanism involving cyclic AMP-dependent phosphorylation. Tremblay J; Lachance B; Hamet P J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(4):397-411. PubMed ID: 2411769 [TBL] [Abstract][Full Text] [Related]
18. Differential effects of two phosphodiesterase inhibitors on fat cell metabolism. Shechter Y Endocrinology; 1984 Nov; 115(5):1787-91. PubMed ID: 6208014 [TBL] [Abstract][Full Text] [Related]
19. Effects of inhibitors of cyclic nucleotide phosphodiesterase on the actions of vasoactive intestinal peptide and secretin on pancreatic acini. Gardner JD; Korman LY; Walker MD; Sutliff VE Am J Physiol; 1982 Jun; 242(6):G547-51. PubMed ID: 6178297 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of prostacyclin synthesis in endothelial cells by methylisobutylxanthine is not mediated through elevated cAMP level. Hong SL Biochim Biophys Acta; 1983 Dec; 754(3):258-63. PubMed ID: 6197092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]